NXTC
NextCure, Inc.
NASDAQ · Healthcare · Biotechnology · US
$6.66
+5.05%Next report
Analyst consensus
- Next report date
- Oct 30, 2026
- EPS estimate
- -$0.90
- Revenue estimate
- —
Latest reported
- Last report date
- Aug 6, 2026
- EPS actual
- -$2.80
- EPS estimate
- -$1.95
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 5
- EPS misses (12Q)
- 7
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +9.5%
- Revenue beats (12Q)
- —
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 6, 2026 | -$1.95 | -$2.80 | Miss -43.59% | — |
| May 7, 2026 | -$1.81 | -$1.87 | Miss -3.31% | — |
| Mar 5, 2026 | -$2.26 | -$0.81 | Beat 64.16% | — |
| Nov 5, 2025 | -$4.06 | -$3.22 | Beat 20.69% | — |
| Aug 7, 2025 | -$4.62 | -$11 | Miss -144.37% | — |
| May 1, 2025 | -$4.80 | -$4.68 | Beat 2.50% | — |
| Mar 6, 2025 | -$0.34 | -$0.41 | Miss -20.59% | — |
| Nov 7, 2024 | -$0.35 | -$0.41 | Miss -17.14% | — |
| Aug 1, 2024 | -$0.36 | -$0.55 | Miss -52.78% | — |
| May 2, 2024 | -$0.45 | -$0.61 | Miss -35.56% | — |
| Mar 21, 2024 | -$0.54 | -$0.52 | Beat 3.70% | $6.3M |
| Nov 2, 2023 | -$0.64 | -$0.51 | Beat 20.31% | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Oct 30, 2026